RT @afederation: Are you working at the frontier of biology?. We’re looking for a few fellow explorers to map the regulome together. The @….

Can't wait!.

RT @johncumbers: 80 Startups Building the Future 🧬 🧬 — and they'll be at #SynBioBeta2025! check 'em out below: @AA….

RT @afederation: How should we think about rare disease drug discovery in today’s economy? I looked at how Syndax is approaching their new….

RT @afederation: Where would genomics be if the BAM/SAM file format was proprietary and Bamtools/Bowtie was closed source and prohibitively….

Congratulations to our co-founder and CTO, Lindsay Pino, for receiving the Rising Star Award from @hupo_org! Her outstanding contributions in research, entrepreneurship and community engagement have expanded the field & breadth of new discovery in proteomics. Well done, Lindsay!

Meet our new Head of Biology, Gaelle Mercenne, featured in @statnews by @EdSilverman. He asked her what piece of lab equipment she’d be, find out when you read the whole conversation in Ed’s “Up & Down the Ladder” for STAT 🔽

We’re proud to welcome Gaelle Mercenne, PhD to Talus Bio as our new Head of Biology. A pioneer at the forefront of AI-accelerated drug discovery, she brings the deep expertise necessary to expand our pipeline of transcription factor therapeutics. See more

With $11.2M in new funding led by @twobearcapital, Talus Bio is set to revolutionize the way we approach drug discovery. Our MARMOT platform is using proteomics and AI to lead the charge against previously "undruggable" transcription factors. Game On!.

RT @VibeBio: VibeCast Episode 47 w/ Dr. Alex Federation, CEO & Co-Founder of @talusbio, is now live!. In this episode w/ host @Healthunchai….

Attending #USHUPO next month in Portland? Here's a sampling of the latest functional proteomics work being presented by Talus Bio's Lindsay Pino, Ph.D. @lkpino, Will Fondrie, Ph.D. @wfondrie, and Bodhi Hueffmeier ⬇️ .This will be the biggest USHUPO ever:

Data drives discovery at Talus Bio. Here's how we integrate the best in science & technology for effective & efficient transcription factor drug discovery ⬇️. #proteomics #transcriptionfactors.#drugdiscovery #teammassspec

#WorldCancerDay: Access to life saving & life-extending #cancer treatments should be equitable for all. We're working to close the treatment gap for hard-to-treat cancers linked to #transcriptionfactor dysregulation. You can take action at

RT @wfondrie: Varun (the first author) was one of our interns last summer @talusbio 🙌.

Our resident platform integration expert Kyle Siebenthall heads to Boston Feb. 3-7 for #SLAS2024 — the premiere conference for the intersection of.#drugdiscovery & lab automation. Reach out to Kyle if you're attending & would like to connect!.#proteomics

Join us for this free virtual event tomorrow at 2PM PT: Biomedical Entrepreneurship & its Unique Challenges. Talus Bio CEO & Co-founder @afederation will join life sciences leaders in a panel discussion led by @ITHS_UW: #biotech #lifesciences

While 1,700+ #transcriptionfactors (TFs) have been identified & 200 linked to cancer, *only 10 TFs* have approved drugs today. Combining new advances in scalable #proteomics & computational biology enables us to target the regulatory proteins driving a wide range of diseases.

📢 Tomorrow @UCBerkeley: Explore cutting-edge #chemoproteomics w/Talus Bio CTO Lindsay Pino, PhD, & @Bruker! . Register for free here:

Connect w/@AFederation & Lindsay Pino next week, Jan 8-12, at the SF Marriott Marquis for BIO's Partnering event at #JPMweek24. Reach out to learn how you can apply Talus Bio's technology to accelerate your company's #drugdiscovery efforts.

We're closing out this year grateful to have spent 2023 in good company — with team members who continue to push the boundaries of science across various fields. We look forward to expanding the limits of drug discovery with scalable #proteomics & #massspectrometry in 2024!